• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Weakened humoral immune responses of inactivated SARS-CoV-2 vaccines in patients with solid tumors.

作者信息

Chen Zhiwei, Zhu Peng, Liu Zuojin, Zhu Bin, Yin Guobing, Ming Jia, Song Rui, Pan Qingbo, Li Tong, Jiang Xingwei, Wang Bing, Liu Shuaibin, Cai Hongxing, Wang Jingjie, Han Yuling, Lin Zijing, Hong Yang, Chen Min, Peng Mingli, Hu Lina, Cai Dachuan, Ren Hong

机构信息

Department of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, P. R. China.

Department of Gastrointestinal Surgery, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, P. R. China.

出版信息

Cancer Commun (Lond). 2023 Feb;43(2):280-284. doi: 10.1002/cac2.12368. Epub 2022 Nov 4.

DOI:10.1002/cac2.12368
PMID:36330800
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9877898/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc8/9926956/686e92ebe08a/CAC2-43-280-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc8/9926956/686e92ebe08a/CAC2-43-280-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc8/9926956/686e92ebe08a/CAC2-43-280-g001.jpg

相似文献

1
Weakened humoral immune responses of inactivated SARS-CoV-2 vaccines in patients with solid tumors.实体瘤患者中灭活新型冠状病毒疫苗的体液免疫反应减弱。
Cancer Commun (Lond). 2023 Feb;43(2):280-284. doi: 10.1002/cac2.12368. Epub 2022 Nov 4.
2
Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.在真实环境中评估灭活 COVID-19 疫苗诱导的 SARS-CoV-2 特异性体液和细胞免疫应答的特征。
Front Immunol. 2021 Dec 22;12:802858. doi: 10.3389/fimmu.2021.802858. eCollection 2021.
3
A three-dose inactivated SARS-CoV-2 vaccine is sufficient to elicit humoral immune responses in people living with HIV-1.三剂灭活严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗足以在感染人类免疫缺陷病毒1型（HIV-1）的人群中引发体液免疫反应。
Chin Med J (Engl). 2023 Sep 20;136(18):2243-2245. doi: 10.1097/CM9.0000000000002810. Epub 2023 Aug 17.
4
Waning humoral immune responses to inactivated SARS-CoV-2 vaccines in patients with severe liver disease.重症肝病患者对新型冠状病毒2型灭活疫苗的体液免疫反应减弱。
Signal Transduct Target Ther. 2022 Jun 2;7(1):174. doi: 10.1038/s41392-022-01032-9.
5
Blunted humoral response after mRNA vaccine in patients with haematological malignancies.血液系统恶性肿瘤患者接种mRNA疫苗后体液免疫反应减弱。
Lancet Haematol. 2021 Aug;8(8):e540-e542. doi: 10.1016/S2352-3026(21)00197-6. Epub 2021 Jul 2.
6
A longitudinal study of humoral immune responses induced by a 3-dose inactivated COVID-19 vaccine in an observational, prospective cohort.一项关于三剂灭活新冠疫苗在观察性前瞻性队列中诱导的体液免疫反应的纵向研究。
BMC Immunol. 2022 Nov 16;23(1):57. doi: 10.1186/s12865-022-00532-1.
7
Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days.接种 COVID-19 mRNA 疫苗后，需要数天才能诱导针对 SARS-CoV-2 的高特异性体液和细胞反应。
Front Immunol. 2021 Oct 4;12:726960. doi: 10.3389/fimmu.2021.726960. eCollection 2021.
8
[Investigation of SARS-CoV-2-Specific Humoral and Cellular Immunity Values in Health Care Workers with COVID-19 Disease and Administered with COVID-19 Vaccine].[对感染新冠病毒疾病并接种新冠疫苗的医护人员的新冠病毒特异性体液免疫和细胞免疫值的调查]
Mikrobiyol Bul. 2022 Jul;56(3):480-492. doi: 10.5578/mb.20229708.
9
T 2 cells associate with enhanced humoral immunity to SARS-CoV-2 inactivated vaccine in patients with allergic rhinitis.在过敏性鼻炎患者中，T2细胞与针对新冠病毒灭活疫苗的体液免疫增强相关。
Clin Transl Med. 2022 Jan;12(1):e717. doi: 10.1002/ctm2.717.
10
Current scenario of COVID-19 vaccinations and immune response along with antibody titer in vaccinated inhabitants of different countries.不同国家接种者的 COVID-19 疫苗接种现状和免疫反应及抗体滴度。
Int Immunopharmacol. 2021 Oct;99:108050. doi: 10.1016/j.intimp.2021.108050. Epub 2021 Aug 6.

引用本文的文献

1
How does geographical diversity shape vaccine efficacy?地理多样性如何影响疫苗效力？
Clin Exp Vaccine Res. 2024 Oct;13(4):271-300. doi: 10.7774/cevr.2024.13.4.271. Epub 2024 Oct 31.
2
Safety and Immunogenicity After Primary and Booster Inactivated SARS-Cov-2 Vaccination in Patients with Autoimmune Liver Diseases.自身免疫性肝病患者初次和加强接种灭活新冠病毒疫苗后的安全性和免疫原性
J Clin Transl Hepatol. 2024 Feb 28;12(2):162-171. doi: 10.14218/JCTH.2023.00049. Epub 2023 Sep 6.
3
Humoral immune responses to inactivated COVID-19 vaccine up to 1 year in children with chronic hepatitis B infection.
儿童慢性乙型肝炎感染者接种灭活 COVID-19 疫苗后 1 年内的体液免疫反应。
Front Cell Infect Microbiol. 2023 Jun 29;13:1201101. doi: 10.3389/fcimb.2023.1201101. eCollection 2023.